{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T23:27:07Z","timestamp":1786750027964,"version":"build-2736575974"},"reference-count":178,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T00:00:00Z","timestamp":1786665600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"abstract":"<jats:p>Protein farnesylation, catalyzed by farnesyltransferase (FTase), covalently attaches a 15-carbon farnesyl lipid to cysteine residues within C-terminal CaaX motifs. This modification governs the subcellular localization, protein\u2013protein interactions, and activity of diverse eukaryotic proteins, including Ras GTPases, nuclear lamins, molecular chaperones, and kinetochore components. This review examines FTase enzymology, substrate recognition, and the sequential post-farnesylation processing by RCE1 and ICMT, alongside the expanding farnesylated proteome and its roles in signaling, nuclear integrity, and mitosis. Central to oncogenic Ras function, farnesylation drove the development of FTase inhibitors (FTIs) as anticancer agents; although alternative prenylation of K-Ras and N-Ras limits efficacy in solid tumors, FTIs show clinical activity in hematologic malignancies. The critical importance of farnesylation is highlighted in Hutchinson\u2013Gilford progeria syndrome, where permanently farnesylated progerin disrupts nuclear architecture, and the FTI lonafarnib extends patient survival. Emerging roles\u2014including driving K-Ras liquid\u2013liquid phase separation and contributing to neurodegeneration and pulmonary hypertension\u2014further broaden the pathophysiological relevance of this modification. Targeting farnesylation through dual prenylation inhibitors, PROTACs, and mevalonate pathway modulation offers promising therapeutic strategies across cancer, progeroid syndromes, and age-related diseases.<\/jats:p>","DOI":"10.3389\/fphar.2026.1907367","type":"journal-article","created":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T22:51:42Z","timestamp":1786747902000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Protein farnesylation: from molecular mechanisms to therapeutic targeting in cancer, aging, and beyond"],"prefix":"10.3389","volume":"17","author":[{"given":"Jiacheng","family":"Lou","sequence":"first","affiliation":[{"name":"Department of Pediatrics, The Second Hospital of Dalian Medical University","place":["Dalian, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danlu","family":"Zhang","sequence":"additional","affiliation":[{"name":"Human Resources Department, The Second Hospital of Dalian Medical University","place":["Dalian, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingjie","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, The Second Hospital of Dalian Medical University","place":["Dalian, China"]},{"name":"Pediatric Oncology and Hematology Center, The Second Affiliated Hospital of Dalian Medical University","place":["Dalian, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,8,14]]},"reference":[{"key":"B1","first-page":"1871","article-title":"A Phase I trial of the farnesyl transferase inhibitor SCH66336: evidence for biological and clinical activity","volume":"60","author":"Adjei","year":"2000","journal-title":"Cancer Res."},{"key":"B2","first-page":"2520","article-title":"A Phase I trial of the farnesyl protein transferase inhibitor R115777 in combination with gemcitabine and cisplatin in patients with advanced cancer","volume":"9","author":"Adjei","year":"","journal-title":"Clin. Cancer Res."},{"key":"B3","doi-asserted-by":"publisher","first-page":"1760","DOI":"10.1200\/JCO.2003.09.075","article-title":"Phase II study of the farnesyl transferase inhibitor R115777 in patients with advanced non-small-cell lung cancer","volume":"21","author":"Adjei","year":"","journal-title":"J. Clin. Oncol."},{"key":"B4","doi-asserted-by":"publisher","first-page":"3271","DOI":"10.1182\/blood-2003-08-2764","article-title":"Farnesyltransferase inhibitor tipifarnib is well tolerated, induces stabilizationFarnesyltransferase inhibitor tipifarnib is well tolerated, induces stabilization of disease, and inhibits farnesylation and oncogenic\/tumor survival pathways in patients with advanced multiple myeloma","volume":"103","author":"Alsina","year":"2004","journal-title":"Blood"},{"key":"B5","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1016\/0092-8674(94)90271-2","article-title":"Membrane targeting of the nucleotide exchange factor Sos is sufficient for activating the Ras signaling pathway","volume":"78","author":"Aronheim","year":"1994","journal-title":"Cell"},{"key":"B6","doi-asserted-by":"publisher","first-page":"4613","DOI":"10.1073\/pnas.89.10.4613","article-title":"Endoproteolytic processing of a farnesylated peptide in vitro","volume":"89","author":"Ashby","year":"1992","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"B7","doi-asserted-by":"publisher","first-page":"eabh3489","DOI":"10.1126\/scitranslmed.abh3489","article-title":"Farnesol prevents aging-related muscle weakness in mice through enhanced farnesylation of Parkin-interacting substrate","volume":"15","author":"Bae","year":"2023","journal-title":"Sci. Transl. Med."},{"key":"B8","doi-asserted-by":"publisher","first-page":"1700","DOI":"10.1038\/s41467-018-03770-3","article-title":"Targeting of NAT10 enhances healthspan in a mouse model of human accelerated aging syndrome","volume":"9","author":"Balmus","year":"2018","journal-title":"Nat. Commun."},{"key":"B9","doi-asserted-by":"publisher","first-page":"2282","DOI":"10.1101\/gad.301242.117","article-title":"Heat-shock protein 40 is the key farnesylation target in meristem size control, abscisic acid signaling, and drought resistance","volume":"31","author":"Barghetti","year":"2017","journal-title":"Genes Dev."},{"key":"B10","doi-asserted-by":"publisher","first-page":"11626","DOI":"10.1073\/pnas.97.21.11626","article-title":"RhoB prenylation is driven by the three carboxyl-terminal amino acids of the protein: evidenced in vivo by an anti-farnesyl cysteine antibody","volume":"97","author":"Baron","year":"2000","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"B11","doi-asserted-by":"publisher","first-page":"1775","DOI":"10.1038\/nprot.2011.387","article-title":"Measurement of protein farnesylation and geranylgeranylation in vitro, in cultured cells and in biopsies, and the effects of prenyl transferase inhibitors","volume":"6","author":"Berndt","year":"2011","journal-title":"Nat. Protoc."},{"key":"B12","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1038\/nrc3151","article-title":"Targeting protein prenylation for cancer therapy","volume":"11","author":"Berndt","year":"2011","journal-title":"Nat. Rev. Cancer"},{"key":"B13","first-page":"1727","article-title":"The farnesyltransferase inhibitor FTI-277 radiosensitizes H-ras-transformed rat embryo fibroblasts","volume":"56","author":"Bernhard","year":"1996","journal-title":"Cancer Res."},{"key":"B14","doi-asserted-by":"publisher","first-page":"2162","DOI":"10.1161\/ATVBAHA.113.301933","article-title":"Lipodystrophy-linked LMNA p.R482W mutation induces clinical early atherosclerosis and in vitro endothelial dysfunction","volume":"33","author":"Bidault","year":"2013","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"B15","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1016\/j.molcel.2006.01.012","article-title":"PKC regulates a farnesyl-electrostatic switch on K-Ras that promotes its association with Bcl-XL on mitochondria and induces apoptosis","volume":"21","author":"Bivona","year":"2006","journal-title":"Mol. Cell"},{"key":"B16","doi-asserted-by":"publisher","first-page":"e2105","DOI":"10.1038\/cddis.2015.374","article-title":"Drug screening on Hutchinson Gilford progeria pluripotent stem cells reveals aminopyrimidines as new modulators of farnesylation","volume":"7","author":"Blondel","year":"2016","journal-title":"Cell Death Dis."},{"key":"B17","first-page":"3894","article-title":"A phase I and pharmacological study of the farnesyl protein transferase inhibitor L-778,123 in patients with solid malignancies","volume":"7","author":"Britten","year":"2001","journal-title":"Clin. Cancer Res."},{"key":"B18","doi-asserted-by":"publisher","first-page":"8313","DOI":"10.1073\/pnas.89.17.8313","article-title":"Tetrapeptide inhibitors of protein farnesyltransferase: amino-terminal substitution in phenylalanine-containing tetrapeptides restores farnesylation","volume":"89","author":"Brown","year":"1992","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"B19","doi-asserted-by":"publisher","first-page":"15149","DOI":"10.1073\/pnas.2535442100","article-title":"A class of sterol 14-demethylase inhibitors as anti-trypanosoma cruzi agents","volume":"100","author":"Buckner","year":"2003","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"B20","doi-asserted-by":"publisher","first-page":"1275","DOI":"10.1073\/pnas.91.4.1275","article-title":"Consequences of altered isoprenylation targets on a-factor export and","volume":"91","author":"Caldwell","year":"1994","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"B21","doi-asserted-by":"publisher","first-page":"4949","DOI":"10.1073\/pnas.0611640104","article-title":"A lamin A protein isoform overexpressed in Hutchinson-Gilford progeria syndrome interferes with mitosis in progeria and normal cells","volume":"104","author":"Cao","year":"2007","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"B22","doi-asserted-by":"publisher","first-page":"12879","DOI":"10.1073\/pnas.0506001102","article-title":"Inhibiting farnesylation of progerin prevents the characteristic nuclear blebbing of Hutchinson-Gilford progeria syndrome","volume":"102","author":"Capell","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"B23","doi-asserted-by":"publisher","first-page":"1759","DOI":"10.1038\/sj.cdd.4402197","article-title":"Human lipodystrophies linked to mutations in A-type lamins and to HIV protease inhibitor therapy are both associated with prelamin A accumulation, oxidative stress and premature cellular senescence","volume":"14","author":"Caron","year":"2007","journal-title":"Cell Death Differ."},{"key":"B24","doi-asserted-by":"publisher","first-page":"8323","DOI":"10.1073\/pnas.86.21.8323","article-title":"p21ras is modified by a farnesyl isoprenoid","volume":"86","author":"Casey","year":"1989","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"B25","doi-asserted-by":"publisher","first-page":"101676","DOI":"10.1016\/j.redox.2020.101676","article-title":"A new target for an old DUB: UCH-L1 regulates mitofusin-2 levels, altering mitochondrial morphology, function and calcium uptake","volume":"37","author":"Cerqueira","year":"2020","journal-title":"Redox Biol."},{"key":"B26","doi-asserted-by":"publisher","first-page":"3578","DOI":"10.1073\/pnas.1809683116","article-title":"Imbalanced nucleocytoskeletal connections create common polarity defects in progeria and physiological aging","volume":"116","author":"Chang","year":"2019","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"B27","doi-asserted-by":"publisher","first-page":"11085","DOI":"10.1073\/pnas.1302564110","article-title":"Prenylome profiling reveals S-farnesylation is crucial for membrane targeting and antiviral activity of ZAP long-isoform","volume":"110","author":"Charron","year":"2013","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"B28","doi-asserted-by":"publisher","first-page":"8206","DOI":"10.1021\/ja0124717","article-title":"Photoaffinity analogues of farnesyl pyrophosphate transferable by protein farnesyl transferase","volume":"124","author":"Chehade","year":"2002","journal-title":"J. Am. Chem. Soc."},{"key":"B29","doi-asserted-by":"publisher","first-page":"e11530","DOI":"10.1002\/advs.202511530","article-title":"Farnesyltransferase deficiency in cardiomyocytes initiates senescence and contributes to cardiac fibrosis","volume":"13","author":"Chen","year":"2026","journal-title":"Adv. Sci. (Weinh)"},{"key":"B30","doi-asserted-by":"publisher","first-page":"13432","DOI":"10.1073\/pnas.0704212104","article-title":"HIV protease inhibitors block the zinc metalloproteinase ZMPSTE24 and lead to an accumulation of prelamin A in cells","volume":"104","author":"Coffinier","year":"2007","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"B31","doi-asserted-by":"publisher","first-page":"1301","DOI":"10.1200\/JCO.2003.08.040","article-title":"Phase II and pharmacodynamic study of the farnesyltransferase inhibitor R115777 as initial therapy in patients with metastatic pancreatic adenocarcinoma","volume":"21","author":"Cohen","year":"2003","journal-title":"J. Clin. Oncol."},{"key":"B32","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1186\/s13024-022-00561-9","article-title":"Farnesyltransferase inhibitor LNK-754 attenuates axonal dystrophy and reduces amyloid pathology in mice","volume":"17","author":"Cuddy","year":"2022","journal-title":"Mol. Neurodegener."},{"key":"B33","doi-asserted-by":"publisher","first-page":"eaea1226","DOI":"10.1126\/sciadv.aea1226","article-title":"Membrane-associated Rhes-Slc4a7 complex orchestrates tunneling nanotube formation and mutant Huntingtin spread","volume":"12","author":"Dagar","year":"2026","journal-title":"Sci. Adv."},{"key":"B34","first-page":"3295","article-title":"The farnesyl protein transferase inhibitor BZA-5B blocks farnesylation of nuclear lamins and p21ras but does not affect their function or localization","volume":"55","author":"Dalton","year":"1995","journal-title":"Cancer Res."},{"key":"B35","doi-asserted-by":"publisher","first-page":"4955","DOI":"10.1073\/pnas.0700854104","article-title":"Alterations in mitosis and cell cycle progression caused by a mutant lamin A known to accelerate human aging","volume":"104","author":"Dechat","year":"2007","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"B36","doi-asserted-by":"publisher","first-page":"E6766","DOI":"10.1073\/pnas.1615316113","article-title":"Structural basis of recognition of farnesylated and methylated KRAS4b by PDEdelta","volume":"113","author":"Dharmaiah","year":"2016","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"B37","doi-asserted-by":"publisher","first-page":"4872","DOI":"10.1182\/blood-2011-02-334870","article-title":"Cytotoxicity of farnesyltransferase inhibitors in lymphoid cells mediated by MAPK pathway inhibition and Bim up-regulation","volume":"118","author":"Ding","year":"2011","journal-title":"Blood"},{"key":"B38","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1093\/cvr\/cvw258","article-title":"Tipifarnib prevents development of hypoxia-induced pulmonary hypertension","volume":"113","author":"Duluc","year":"2017","journal-title":"Cardiovasc Res."},{"key":"B39","doi-asserted-by":"publisher","first-page":"1877","DOI":"10.1158\/1078-0432.CCR-04-1769","article-title":"A phase I trial of the novel farnesyl protein transferase inhibitor, BMS-214662, in combination with paclitaxel and carboplatin in patients with advanced cancer","volume":"11","author":"Dy","year":"2005","journal-title":"Clin. Cancer Res."},{"key":"B40","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1007\/s00401-021-02279-2","article-title":"Patterns of neuronal rhes as a novel hallmark of tauopathies","volume":"141","author":"Ehrenberg","year":"2021","journal-title":"Acta Neuropathol."},{"key":"B41","doi-asserted-by":"publisher","first-page":"14635","DOI":"10.1038\/ncomms14635","article-title":"Allosteric modulation of peroxisomal membrane protein recognition by farnesylation of the peroxisomal import receptor PEX19","volume":"8","author":"Emmanouilidis","year":"2017","journal-title":"Nat. Commun."},{"key":"B42","first-page":"131","article-title":"Characterization of the antitumor effects of the selective farnesyl protein transferase inhibitor R115777 in vivo and in vitro","volume":"61","author":"End","year":"2001","journal-title":"Cancer Res."},{"key":"B43","doi-asserted-by":"publisher","first-page":"1707","DOI":"10.1038\/leu.2008.156","article-title":"On the use of lonafarnib in myelodysplastic syndrome and chronic myelomonocytic leukemia","volume":"22","author":"Feldman","year":"2008","journal-title":"Leukemia"},{"key":"B44","doi-asserted-by":"publisher","first-page":"1353","DOI":"10.1111\/jipb.13093","article-title":"Protein farnesylation negatively regulates brassinosteroid signaling via reducing BES1 stability in Arabidopsis thaliana","volume":"63","author":"Feng","year":"2021","journal-title":"J. Integr. Plant Biol."},{"key":"B45","doi-asserted-by":"publisher","first-page":"4448","DOI":"10.1073\/pnas.88.10.4448","article-title":"Protein geranylgeranyltransferase of Saccharomyces cerevisiae is specific for Cys-Xaa-Xaa-Leu motif proteins and requires the CDC43 gene product but not the DPR1 gene product","volume":"88","author":"Finegold","year":"1991","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"B46","doi-asserted-by":"publisher","first-page":"3153","DOI":"10.1158\/0008-5472.CAN-05-3116","article-title":"PRL tyrosine phosphatases regulate rho family GTPases to promote invasion and motility","volume":"66","author":"Fiordalisi","year":"2006","journal-title":"Cancer Res."},{"key":"B47","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1083\/jcb.129.1.17","article-title":"Analysis of nuclear lamin isoprenylation in Xenopus oocytes: isoprenylation of lamin B3 precedes its uptake into the nucleus","volume":"129","author":"Firmbach-Kraft","year":"1995","journal-title":"J. Cell Biol."},{"key":"B48","doi-asserted-by":"publisher","first-page":"e14105","DOI":"10.1111\/acel.14105","article-title":"Genetic and pharmacological modulation of lamin A farnesylation determines its function and turnover","volume":"23","author":"Foo","year":"2024","journal-title":"Aging Cell"},{"key":"B49","doi-asserted-by":"publisher","first-page":"880","DOI":"10.1038\/s41419-019-2109-9","article-title":"The differential statin effect on cytokine production of monocytes or macrophages is mediated by differential geranylgeranylation-dependent Rac1 activation","volume":"10","author":"Fu","year":"2019","journal-title":"Cell Death Dis."},{"key":"B50","doi-asserted-by":"publisher","first-page":"4815","DOI":"10.1073\/pnas.0401183101","article-title":"Localization and activity of the SNARE Ykt6 determined by its regulatory domain and palmitoylation","volume":"101","author":"Fukasawa","year":"2004","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"B51","doi-asserted-by":"publisher","first-page":"7250","DOI":"10.1093\/emboj\/16.24.7250","article-title":"Induction of the cholesterol metabolic pathway regulates the farnesylation of RAS in embryonic chick heart cells: a new role for ras in regulating the expression of muscarinic receptors and G proteins","volume":"16","author":"Gadbut","year":"1997","journal-title":"EMBO J."},{"key":"B52","doi-asserted-by":"publisher","first-page":"1784","DOI":"10.1158\/1535-7163.MCT-19-0958","article-title":"Tipifarnib as a precision therapy for HRAS-mutant head and neck squamous cell carcinomas","volume":"19","author":"Gilardi","year":"2020","journal-title":"Mol. Cancer Ther."},{"key":"B53","doi-asserted-by":"publisher","first-page":"9665","DOI":"10.1073\/pnas.87.24.9665","article-title":"Mutants of Saccharomyces cerevisiae defective in the farnesylation of Ras proteins","volume":"87","author":"Goodman","year":"1990","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"B54","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1161\/circulationaha.113.008285","article-title":"Impact of farnesylation inhibitors on survival in hutchinson-gilford progeria syndrome","volume":"130","author":"Gordon","year":"2014","journal-title":"Circulation"},{"key":"B55","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1161\/CIRCULATIONAHA.116.022188","article-title":"Clinical trial of the protein farnesylation inhibitors lonafarnib, pravastatin, and zoledronic acid in children with hutchinson-gilford progeria syndrome","volume":"134","author":"Gordon","year":"2016","journal-title":"Circulation"},{"key":"B56","doi-asserted-by":"publisher","first-page":"1734","DOI":"10.1161\/CIRCULATIONAHA.122.060002","article-title":"Plasma progerin in patients with hutchinson-gilford progeria syndrome: immunoassay development and clinical evaluation","volume":"147","author":"Gordon","year":"2023","journal-title":"Circulation"},{"key":"B57","doi-asserted-by":"publisher","first-page":"1709","DOI":"10.1093\/annonc\/mdl282","article-title":"A phase I safety, pharmacological and biological study of the farnesyl protein transferase inhibitor, tipifarnib and capecitabine in advanced solid tumors","volume":"17","author":"Gore","year":"2006","journal-title":"Ann. Oncol."},{"key":"B58","first-page":"223","article-title":"Lovastatin induces apoptosis in a metastatic ovarian tumour cell line","volume":"3","author":"Han","year":"1996","journal-title":"Cell Death Differ."},{"key":"B59","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1002\/j.1460-2075.1991.tb07992.x","article-title":"Methylation and proteolysis are essential for efficient membrane binding of prenylated p21K-ras(B)","volume":"10","author":"Hancock","year":"1991","journal-title":"EMBO J."},{"key":"B60","doi-asserted-by":"publisher","first-page":"11373","DOI":"10.1073\/pnas.88.24.11373","article-title":"RAM2, an essential gene of yeast, and RAM1 encode the two polypeptide components of the farnesyltransferase that prenylates a-factor and Ras proteins","volume":"88","author":"He","year":"1991","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"B61","doi-asserted-by":"publisher","first-page":"955","DOI":"10.1111\/acel.12119","article-title":"HIV protease inhibitors induce senescence and alter osteoblastic potential of human bone marrow mesenchymal stem cells: beneficial effect of pravastatin","volume":"12","author":"Hernandez-Vallejo","year":"2013","journal-title":"Aging Cell"},{"key":"B62","doi-asserted-by":"publisher","first-page":"1187","DOI":"10.1093\/annonc\/mdh315","article-title":"Phase II study of the farnesyl transferase inhibitor R11577 in patients with sensitive relapse small-cell lung cancer","volume":"15","author":"Heymach","year":"2004","journal-title":"Ann. Oncol."},{"key":"B63","doi-asserted-by":"publisher","first-page":"1856","DOI":"10.1200\/JCO.20.02903","article-title":"Tipifarnib in head and neck squamous cell carcinoma with HRAS mutations","volume":"39","author":"Ho","year":"2021","journal-title":"J. Clin. Oncol."},{"key":"B64","doi-asserted-by":"publisher","first-page":"4432","DOI":"10.1039\/d0sc05838f","article-title":"Different phosphorylation and farnesylation patterns tune Rnd3-14-3-3 interaction in distinct mechanisms","volume":"12","author":"Hu","year":"2021","journal-title":"Chem. Sci."},{"key":"B65","doi-asserted-by":"publisher","first-page":"1937","DOI":"10.1126\/science.8316834","article-title":"Benzodiazepine peptidomimetics: potent inhibitors of ras farnesylation in animal cells","volume":"260","author":"James","year":"1993","journal-title":"Science"},{"key":"B66","doi-asserted-by":"publisher","first-page":"4454","DOI":"10.1073\/pnas.93.9.4454","article-title":"Resistance of K-RasBV12 proteins to farnesyltransferase inhibitors in Rat1 cells","volume":"93","author":"James","year":"1996","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"B67","doi-asserted-by":"publisher","first-page":"eaax8891","DOI":"10.1126\/scitranslmed.aax8891","article-title":"PARIS farnesylation prevents neurodegeneration in models of Parkinson\u2019s disease","volume":"13","author":"Jo","year":"2021","journal-title":"Sci. Transl. Med."},{"key":"B68","doi-asserted-by":"publisher","first-page":"2492","DOI":"10.1200\/JCO.2003.10.064","article-title":"Phase II study of the efficacy and tolerability of two dosing regimens of the farnesyl transferase inhibitor, R115777, in advanced breast cancer","volume":"21","author":"Johnston","year":"2003","journal-title":"J. Clin. Oncol."},{"key":"B69","doi-asserted-by":"publisher","first-page":"E1923","DOI":"10.1073\/pnas.1303916110","article-title":"Farnesylation of lamin B1 is important for retention of nuclear chromatin during neuronal migration","volume":"110","author":"Jung","year":"2013","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"B70","doi-asserted-by":"publisher","first-page":"383","DOI":"10.3727\/095535491820873704","article-title":"Post-translational processing of purified human K-ras in xenopus oocytes","volume":"3","author":"Kaplan","year":"1991","journal-title":"Cancer Commun."},{"key":"B71","doi-asserted-by":"publisher","first-page":"3361","DOI":"10.1182\/blood.v97.11.3361","article-title":"Clinical and biologic activity of the farnesyltransferase inhibitor R115777 in adults with refractory and relapsed acute leukemias: a phase 1 clinical-laboratory correlative trial","volume":"97","author":"Karp","year":"2001","journal-title":"Blood"},{"key":"B72","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1016\/j.neuron.2005.07.025","article-title":"Farnesylation of retinal transducin underlies its translocation during light adaptation","volume":"47","author":"Kassai","year":"2005","journal-title":"Neuron"},{"key":"B73","doi-asserted-by":"publisher","first-page":"6403","DOI":"10.1073\/pnas.89.14.6403","article-title":"Isoprenoid addition to ras protein is the critical modification for its membrane association and transforming activity","volume":"89","author":"Kato","year":"1992","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"B74","doi-asserted-by":"publisher","first-page":"5984","DOI":"10.1158\/1078-0432.CCR-18-3399","article-title":"Dual farnesyl and geranylgeranyl transferase inhibitor thwarts mutant KRAS-driven patient-derived pancreatic tumors","volume":"25","author":"Kazi","year":"2019","journal-title":"Clin. Cancer Res."},{"key":"B75","first-page":"3544","article-title":"Preclinical antitumor activity and pharmacodynamic studies with the farnesyl protein transferase inhibitor R115777 in human breast cancer","volume":"7","author":"Kelland","year":"2001","journal-title":"Clin. Cancer Res."},{"key":"B76","doi-asserted-by":"publisher","first-page":"12479","DOI":"10.1073\/pnas.0403413101","article-title":"A tagging-via-substrate technology for detection and proteomics of farnesylated proteins","volume":"101","author":"Kho","year":"2004","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"B77","doi-asserted-by":"publisher","first-page":"3137","DOI":"10.1200\/JCO.2006.09.4243","article-title":"Phase I and pharmacokinetic study of the oral farnesyltransferase inhibitor lonafarnib administered twice daily to pediatric patients with advanced central nervous system tumors using a modified continuous reassessment method: a pediatric brain tumor consortium study","volume":"25","author":"Kieran","year":"2007","journal-title":"J. Clin. Oncol."},{"key":"B78","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1016\/j.canlet.2009.06.010","article-title":"Ras activation contributes to the maintenance and expansion of Sca-1pos cells in a mouse model of breast cancer","volume":"287","author":"Kim","year":"2010","journal-title":"Cancer Lett."},{"key":"B79","doi-asserted-by":"publisher","first-page":"2572","DOI":"10.1038\/s41467-022-30149-2","article-title":"AIMP2-DX2 provides therapeutic interface to control KRAS-Driven tumorigenesis","volume":"13","author":"Kim","year":"2022","journal-title":"Nat. Commun."},{"key":"B80","doi-asserted-by":"publisher","first-page":"8934","DOI":"10.1073\/pnas.88.20.8934","article-title":"Posttranslational modification of Ha-ras p21 by farnesyl versus geranylgeranyl isoprenoids is determined by the COOH-terminal amino acid","volume":"88","author":"Kinsella","year":"1991","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"B81","doi-asserted-by":"publisher","first-page":"1934","DOI":"10.1126\/science.8316833","article-title":"Selective inhibition of ras-dependent transformation by a farnesyltransferase inhibitor","volume":"260","author":"Kohl","year":"1993","journal-title":"Science"},{"key":"B82","doi-asserted-by":"publisher","first-page":"7386","DOI":"10.1158\/0008-5472.CAN-07-0993","article-title":"Statin-induced breast cancer cell death: role of inducible nitric oxide and arginase-dependent pathways","volume":"67","author":"Kotamraju","year":"2007","journal-title":"Cancer Res."},{"key":"B83","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1126\/science.8430318","article-title":"The effect of posttranslational modifications on the interaction of Ras2 with adenylyl cyclase","volume":"259","author":"Kuroda","year":"1993","journal-title":"Science"},{"key":"B84","doi-asserted-by":"publisher","first-page":"1387","DOI":"10.1182\/blood-2006-04-014357","article-title":"A phase 2 study of the farnesyltransferase inhibitor tipifarnib in poor-risk and elderly patients with previously untreated acute myelogenous leukemia","volume":"109","author":"Lancet","year":"2007","journal-title":"Blood"},{"key":"B85","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1080\/14756366.2022.2135510","article-title":"Synthesis and discovery of the first potent proteolysis targeting chimaera (PROTAC) degrader of AIMP2-DX2 as a lung cancer drug","volume":"38","author":"Lee","year":"2023","journal-title":"J. Enzyme Inhib. Med. Chem."},{"key":"B86","doi-asserted-by":"publisher","first-page":"114033","DOI":"10.1016\/j.celrep.2024.114033","article-title":"The Legionella pneumophila effector DenR hijacks the host NRas proto-oncoprotein to downregulate MAPK signaling","volume":"43","author":"Lehman","year":"2024","journal-title":"Cell Rep."},{"key":"B87","doi-asserted-by":"publisher","first-page":"1524","DOI":"10.1038\/s41467-018-03913-6","article-title":"Inhibition of the mevalonate pathway enhances cancer cell oncolysis mediated by M1 virus","volume":"9","author":"Liang","year":"2018","journal-title":"Nat. Commun."},{"key":"B88","doi-asserted-by":"publisher","first-page":"4635","DOI":"10.1073\/pnas.0806474106","article-title":"Membrane-associated farnesylated UCH-L1 promotes alpha-synuclein neurotoxicity and is a therapeutic target for Parkinson\u2019s disease","volume":"106","author":"Liu","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"B89","doi-asserted-by":"publisher","first-page":"6471","DOI":"10.1073\/pnas.0908396107","article-title":"Targeting the protein prenyltransferases efficiently reduces tumor development in mice with K-RAS-induced lung cancer","volume":"107","author":"Liu","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"B90","first-page":"8758","article-title":"Evaluation of farnesyl:protein transferase and geranylgeranyl:protein transferase inhibitor combinations in preclinical models","volume":"61","author":"Lobell","year":"2001","journal-title":"Cancer Res."},{"key":"B91","doi-asserted-by":"crossref","first-page":"12948","DOI":"10.1073\/pnas.241407898","article-title":"The crystal structure of human protein farnesyltransferase reveals the basis for inhibition by CaaX tetrapeptides and their mimetics","volume":"98","author":"Long","year":"2001","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"B92","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1038\/nature00986","article-title":"Reaction path of protein farnesyltransferase at atomic resolution","volume":"419","author":"Long","year":"2002","journal-title":"Nature"},{"key":"B93","doi-asserted-by":"publisher","first-page":"3000","DOI":"10.1073\/pnas.89.7.3000","article-title":"Nucleoplasmic localization of prelamin A: implications for prenylation-dependent lamin A assembly into the nuclear lamina","volume":"89","author":"Lutz","year":"1992","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"B94","doi-asserted-by":"publisher","first-page":"958","DOI":"10.1021\/ja1086112","article-title":"Bivalent inhibitors for disrupting protein surface-substrate interactions and for dual inhibition of protein prenyltransferases","volume":"133","author":"Machida","year":"2011","journal-title":"J. Am. Chem. Soc."},{"key":"B95","doi-asserted-by":"publisher","first-page":"14416","DOI":"10.1073\/pnas.0503712102","article-title":"Inhibiting farnesylation reverses the nuclear morphology defect in a HeLa cell model for Hutchinson-Gilford progeria syndrome","volume":"102","author":"Mallampalli","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"B96","doi-asserted-by":"publisher","first-page":"7541","DOI":"10.1073\/pnas.87.19.7541","article-title":"Identification and preliminary characterization of protein-cysteine farnesyltransferase","volume":"87","author":"Manne","year":"1990","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"B97","doi-asserted-by":"publisher","first-page":"3883","DOI":"10.1158\/0008-5472.CAN-04-3757","article-title":"The synergistic combination of the farnesyl transferase inhibitor lonafarnib and paclitaxel enhances tubulin acetylation and requires a functional tubulin deacetylase","volume":"65","author":"Marcus","year":"2005","journal-title":"Cancer Res."},{"key":"B98","doi-asserted-by":"publisher","first-page":"1982","DOI":"10.1182\/blood-2006-06-031088","article-title":"Farnesyltransferase inhibitors inhibit T-cell cytokine production at the posttranscriptional level","volume":"110","author":"Marks","year":"2007","journal-title":"Blood"},{"key":"B99","doi-asserted-by":"publisher","first-page":"5447","DOI":"10.1158\/1078-0432.CCR-04-0248","article-title":"A phase I trial of the dual farnesyltransferase and geranylgeranyltransferase inhibitor L-778,123 and radiotherapy for locally advanced pancreatic cancer","volume":"10","author":"Martin","year":"2004","journal-title":"Clin. Cancer Res."},{"key":"B100","doi-asserted-by":"publisher","first-page":"1599","DOI":"10.1038\/sj.leu.2403469","article-title":"Farnesyltransferase inhibitor BMS-214662 induces apoptosis in B-cell chronic lymphocytic leukemia cells","volume":"18","author":"Marzo","year":"2004","journal-title":"Leukemia"},{"key":"B101","doi-asserted-by":"publisher","first-page":"1223","DOI":"10.1083\/jcb.200303113","article-title":"A carboxyl-terminal interaction of lamin B1 is dependent on the CAAX endoprotease Rce1 and carboxymethylation","volume":"162","author":"Maske","year":"2003","journal-title":"J. Cell Biol."},{"key":"B102","doi-asserted-by":"publisher","first-page":"1305","DOI":"10.1038\/cdd.2010.183","article-title":"Prelamin A-mediated recruitment of SUN1 to the nuclear envelope directs nuclear positioning in human muscle","volume":"18","author":"Mattioli","year":"2011","journal-title":"Cell Death Differ."},{"key":"B103","doi-asserted-by":"publisher","first-page":"2178","DOI":"10.1101\/gad.1690808","article-title":"Tumorigenic activity and therapeutic inhibition of rheb GTPase","volume":"22","author":"Mavrakis","year":"2008","journal-title":"Genes Dev."},{"key":"B104","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1083\/jcb.152.1.111","article-title":"Differential localization of rho GTPases in live cells: regulation by hypervariable regions and RhoGDI binding","volume":"152","author":"Michaelson","year":"2001","journal-title":"J. Cell Biol."},{"key":"B105","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1016\/j.ccr.2005.03.004","article-title":"Protein farnesyltransferase in embryogenesis, adult homeostasis, and tumor development","volume":"7","author":"Mijimolle","year":"2005","journal-title":"Cancer Cell"},{"key":"B106","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1016\/j.cell.2020.12.029","article-title":"Farnesyltransferase inhibition in HGPS","volume":"184","author":"Misteli","year":"2021","journal-title":"Cell"},{"key":"B107","doi-asserted-by":"publisher","first-page":"6442","DOI":"10.1073\/pnas.88.15.6442","article-title":"A stimulatory GDP\/GTP exchange protein for smg p21 is active on the post-translationally processed form of c-Ki-ras p21 and rhoA p21","volume":"88","author":"Mizuno","year":"1991","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"B108","doi-asserted-by":"publisher","first-page":"1369","DOI":"10.1073\/pnas.95.4.1369","article-title":"Farnesyl transferase inhibitors cause enhanced mitotic sensitivity to taxol and epothilones","volume":"95","author":"Moasser","year":"1998","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"B109","doi-asserted-by":"publisher","first-page":"961","DOI":"10.1083\/jcb.201611060","article-title":"Structure of the RZZ complex and molecular basis of its interaction with spindly","volume":"216","author":"Mosalaganti","year":"2017","journal-title":"J. Cell Biol."},{"key":"B110","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1083\/jcb.201412085","article-title":"A novel role of farnesylation in targeting a mitotic checkpoint protein, human human Spindly, to kinetochores","volume":"208","author":"Moudgil","year":"2015","journal-title":"J. Cell Biol."},{"key":"B111","first-page":"5310","article-title":"Inhibition of human tumor xenograft growth by treatment with the farnesyl transferase inhibitor B956","volume":"55","author":"Nagasu","year":"1995","journal-title":"Cancer Res."},{"key":"B112","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.canlet.2007.01.008","article-title":"Induction of mitochondria-dependent apoptosis through the inhibition of mevalonate pathway in human breast cancer cells by YM529, a new third generation bisphosphonate","volume":"253","author":"Nakajima","year":"2007","journal-title":"Cancer Lett."},{"key":"B113","doi-asserted-by":"publisher","first-page":"5367","DOI":"10.1182\/blood-2011-09-376152","article-title":"Angiogenesis: the HETE is on","volume":"118","author":"Nayak","year":"2011","journal-title":"Blood"},{"key":"B114","first-page":"5896","article-title":"Combination therapy with the farnesyl protein transferase inhibitor SCH66336 and SCH58500 (p53 adenovirus) in preclinical cancer models","volume":"59","author":"Nielsen","year":"1999","journal-title":"Cancer Res."},{"key":"B115","doi-asserted-by":"publisher","first-page":"16114","DOI":"10.1038\/nplants.2016.114","article-title":"Farnesylation mediates brassinosteroid biosynthesis to regulate abscisic acid responses","volume":"2","author":"Northey","year":"2016","journal-title":"Nat. Plants"},{"key":"B116","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1111\/j.1572-0241.2007.01773.x","article-title":"Statins inhibit proliferation and induce apoptosis in Barrett\u2019s esophageal adenocarcinoma cells","volume":"103","author":"Ogunwobi","year":"2008","journal-title":"Am. J. Gastroenterol."},{"key":"B117","doi-asserted-by":"publisher","first-page":"3669","DOI":"10.1002\/j.1460-2075.1991.tb04934.x","article-title":"Carboxyl methylation and farnesylation of transducin gamma-subunit synergistically enhance its coupling with metarhodopsin II","volume":"10","author":"Ohguro","year":"1991","journal-title":"EMBO J."},{"key":"B118","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1038\/emboj.2011.417","article-title":"Optimal functional levels of activation-induced deaminase specifically require the Hsp40 DnaJa1","volume":"31","author":"Orthwein","year":"2012","journal-title":"EMBO J."},{"key":"B119","doi-asserted-by":"publisher","first-page":"2671","DOI":"10.1172\/JCI119812","article-title":"Lovastatin and phenylacetate inhibit the induction of nitric oxide synthase and cytokines in rat primary astrocytes, microglia, and macrophages","volume":"100","author":"Pahan","year":"1997","journal-title":"J. Clin. Invest."},{"key":"B120","doi-asserted-by":"publisher","first-page":"15086","DOI":"10.1021\/ja065838","article-title":"Measurement of the alpha-secondary kinetic isotope effect for the reaction catalyzed by mammalian protein farnesyltransferase","volume":"128","author":"Pais","year":"2006","journal-title":"J. Am. Chem. Soc."},{"key":"B121","doi-asserted-by":"publisher","first-page":"111864","DOI":"10.1016\/j.isci.2025.111864","article-title":"Functional-proteomics-based investigation of the cellular response to farnesyltransferase inhibition in lung cancer","volume":"28","author":"Pan","year":"2025","journal-title":"iScience"},{"key":"B122","first-page":"4761","article-title":"A phase I, pharmacokinetic, and biological study of the farnesyltransferase inhibitor tipifarnib in combination with gemcitabine in patients with advanced malignancies","volume":"9","author":"Patnaik","year":"2003","journal-title":"Clin. Cancer Res."},{"key":"B123","doi-asserted-by":"publisher","first-page":"3043","DOI":"10.1073\/pnas.88.8.3043","article-title":"Methylation and demethylation reactions of guanine nucleotide-binding proteins of retinal rod outer segments","volume":"88","author":"Perez-Sala","year":"1991","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"B124","doi-asserted-by":"publisher","first-page":"11736","DOI":"10.1021\/ja063599x","article-title":"Imaging farnesyl protein transferase using a topologically activated probe","volume":"128","author":"Pham","year":"2006","journal-title":"J. Am. Chem. Soc."},{"key":"B125","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1186\/1476-4598-12-88","article-title":"Combined p21-activated kinase and farnesyltransferase inhibitor treatment exhibits enhanced anti-proliferative activity on melanoma, colon and lung cancer cell lines","volume":"12","author":"Porcu","year":"2013","journal-title":"Mol. Cancer"},{"key":"B126","doi-asserted-by":"publisher","first-page":"1713","DOI":"10.1084\/jem.20100771","article-title":"Exploitation of conserved eukaryotic host cell farnesylation machinery by an F-box effector of Legionella pneumophila","volume":"207","author":"Price","year":"2010","journal-title":"J. Exp. Med."},{"key":"B127","doi-asserted-by":"publisher","first-page":"1553","DOI":"10.1126\/science.1212868","article-title":"Host proteasomal degradation generates amino acids essential for intracellular bacterial growth","volume":"334","author":"Price","year":"2011","journal-title":"Science"},{"key":"B128","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1038\/35070050","article-title":"GTP-Dependent segregation of H-ras from lipid rafts is required for biological activity","volume":"3","author":"Prior","year":"2001","journal-title":"Nat. Cell Biol."},{"key":"B129","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1083\/jcb.200209091","article-title":"Direct visualization of Ras proteins in spatially distinct cell surface microdomains","volume":"160","author":"Prior","year":"2003","journal-title":"J. Cell Biol."},{"key":"B130","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1038\/nrc3106","article-title":"RAS oncogenes: weaving a tumorigenic web","volume":"11","author":"Pylayeva-Gupta","year":"2011","journal-title":"Nat. Rev. Cancer"},{"key":"B131","doi-asserted-by":"publisher","first-page":"2381","DOI":"10.1105\/tpc.8.12.2381","article-title":"Protein farnesyltransferase in plants: molecular characterization and involvement in cell cycle control","volume":"8","author":"Qian","year":"1996","journal-title":"Plant Cell"},{"key":"B132","doi-asserted-by":"publisher","first-page":"2200","DOI":"10.1161\/CIRCULATIONAHA.109.902056","article-title":"Prelamin A acts to accelerate smooth muscle cell senescence and is a novel biomarker of human vascular aging","volume":"121","author":"Ragnauth","year":"2010","journal-title":"Circulation"},{"key":"B133","doi-asserted-by":"publisher","first-page":"1399","DOI":"10.1182\/blood.v97.5.1399","article-title":"Treatment of Bcr\/Abl-positive acute lymphoblastic leukemia in P190 transgenic mice with the farnesyl transferase inhibitor SCH66336","volume":"97","author":"Reichert","year":"2001","journal-title":"Blood"},{"key":"B134","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1083\/jcb.200502115","article-title":"Structurally and functionally unique complexins at retinal ribbon synapses","volume":"169","author":"Reim","year":"2005","journal-title":"J. Cell Biol."},{"key":"B135","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/0092-8674(90)90242-7","article-title":"Inhibition of purified p21ras farnesyl:protein transferase by Cys-AAX tetrapeptides","volume":"62","author":"Reiss","year":"1990","journal-title":"Cell"},{"key":"B136","doi-asserted-by":"publisher","first-page":"1179","DOI":"10.1083\/jcb.151.6.1179","article-title":"Reversal of the ras-induced transformed phenotype by HR12, a novel ras farnesylation inhibitor, is mediated by the Mek\/Erk pathway","volume":"151","author":"Reuveni","year":"2000","journal-title":"J. Cell Biol."},{"key":"B137","doi-asserted-by":"publisher","first-page":"e2003611","DOI":"10.1371\/journal.pbio.2003611","article-title":"Nitric oxide-mediated posttranslational modifications control neurotransmitter release by modulating complexin farnesylation and enhancing its clamping ability","volume":"16","author":"Robinson","year":"2018","journal-title":"PLoS Biol."},{"key":"B138","doi-asserted-by":"publisher","first-page":"2222","DOI":"10.1158\/1078-0432.ccr-0980-3","article-title":"Phase I clinical trial of the farnesyltransferase inhibitor BMS-214662 given as a 1-hour intravenous infusion in patients with advanced solid tumors","volume":"10","author":"Ryan","year":"2004","journal-title":"Clin. Cancer Res."},{"key":"B139","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1016\/j.cub.2017.01.069","article-title":"Compartmentalization of ER-Bound chaperone confines protein deposit formation to the aging yeast cell","volume":"27","author":"Saarikangas","year":"2017","journal-title":"Curr. Biol."},{"key":"B140","doi-asserted-by":"publisher","first-page":"800","DOI":"10.1038\/s41556-018-0130-3","article-title":"Dynamic kinetochore size regulation promotes microtubule capture and chromosome biorientation in mitosis","volume":"20","author":"Sacristan","year":"2018","journal-title":"Nat. Cell Biol."},{"key":"B141","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1038\/ncb3373","article-title":"Peroxin-dependent targeting of a lipid-droplet-destined membrane protein to ER subdomains","volume":"18","author":"Schrul","year":"2016","journal-title":"Nat. Cell Biol."},{"key":"B142","first-page":"5302","article-title":"A peptidomimetic inhibitor of farnesyl:protein transferase blocks the anchorage-dependent and -independent growth of human tumor cell lines","volume":"55","author":"Sepp-Lorenzino","year":"1995","journal-title":"Cancer Res."},{"key":"B143","first-page":"3229","article-title":"An antibody which specifically recognizes prelamin A but not mature lamin A: application to detection of blocks in farnesylation-dependent protein processing","volume":"54","author":"Sinensky","year":"1994","journal-title":"Cancer Res."},{"key":"B144","doi-asserted-by":"publisher","first-page":"5701","DOI":"10.1182\/blood-2011-04-347468","article-title":"12\/15-Lipoxygenase gene knockout severely impairs ischemia-induced angiogenesis due to lack of Rac1 farnesylation","volume":"118","author":"Singh","year":"2011","journal-title":"Blood"},{"key":"B145","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1016\/s0016-5085(99)70449-x","article-title":"Pharmacological inhibition of Ras-transformed epithelial cell growth is linked to down-regulation of epidermal growth factor-related peptides","volume":"117","author":"Sizemore","year":"1999","journal-title":"Gastroenterology"},{"key":"B146","doi-asserted-by":"publisher","first-page":"1463","DOI":"10.1126\/science.7811320","article-title":"Activation of raf as a result of recruitment to the plasma membrane","volume":"264","author":"Stokoe","year":"1994","journal-title":"Science"},{"key":"B147","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1038\/s41557-019-0237-6","article-title":"Dual chemical probes enable quantitative system-wide analysis of protein prenylation and prenylation dynamics","volume":"11","author":"Storck","year":"2019","journal-title":"Nat. Chem."},{"key":"B148","first-page":"4243","article-title":"Ras CAAX peptidomimetic FTI 276 selectively blocks tumor growth in nude mice of a human lung carcinoma with K-Ras mutation and p53 deletion","volume":"55","author":"Sun","year":"1995","journal-title":"Cancer Res."},{"key":"B149","doi-asserted-by":"publisher","first-page":"1161","DOI":"10.1016\/s0959-8049(00)00067-8","article-title":"Inhibition of farnesyltransferase with A-176120, a novel and potent farnesyl pyrophosphate analogue","volume":"36","author":"Tahir","year":"2000","journal-title":"Eur. J. Cancer"},{"key":"B150","doi-asserted-by":"publisher","first-page":"1259","DOI":"10.1016\/s0960-9822(03)00506-2","article-title":"Tuberous sclerosis complex gene products, tuberin and hamartin, control mTOR signaling by acting as a GTPase-activating protein complex toward Rheb","volume":"13","author":"Tee","year":"2003","journal-title":"Curr. Biol."},{"key":"B151","doi-asserted-by":"publisher","first-page":"12873","DOI":"10.1073\/pnas.0505767102","article-title":"Blocking protein farnesyltransferase improves nuclear shape in fibroblasts from humans with progeroid syndromes","volume":"102","author":"Toth","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"B152","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1038\/nm1786","article-title":"Combined treatment with statins and aminobisphosphonates extends longevity in a mouse model of human premature aging","volume":"14","author":"Varela","year":"2008","journal-title":"Nat. Med."},{"key":"B153","doi-asserted-by":"publisher","first-page":"10428","DOI":"10.1073\/pnas.0401424101","article-title":"Lamin B1 is required for mouse development and nuclear integrity","volume":"101","author":"Vergnes","year":"2004","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"B154","doi-asserted-by":"publisher","first-page":"4997","DOI":"10.1073\/pnas.1019532108","article-title":"Protein farnesylation inhibitors cause donut-shaped cell nuclei attributable to a centrosome separation defect","volume":"108","author":"Verstraeten","year":"2011","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"B155","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1182\/blood-2006-05-024752","article-title":"Rce1 deficiency accelerates the development of K-RAS-induced myeloproliferative disease","volume":"109","author":"Wahlstrom","year":"2007","journal-title":"Blood"},{"key":"B156","doi-asserted-by":"publisher","first-page":"1559","DOI":"10.1084\/jem.20121806","article-title":"Altered protein prenylation in sertoli cells is associated with adult infertility resulting from childhood mumps infection","volume":"210","author":"Wang","year":"2013","journal-title":"J. Exp. Med."},{"key":"B157","doi-asserted-by":"publisher","first-page":"4260","DOI":"10.1016\/j.cell.2026.05.002","article-title":"Farnesylation-driven KRAS phase separation promotes Colon tumor growth","volume":"189","author":"Wang","year":"2026","journal-title":"Cell"},{"key":"B158","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1016\/j.molcel.2010.01.024","article-title":"Lipid-induced conformational switch controls fusion activity of longin domain SNARE Ykt6","volume":"37","author":"Wen","year":"2010","journal-title":"Mol. Cell"},{"key":"B159","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1200\/JCO.2005.03.8638","article-title":"Phase I trial and pharmacokinetic study of the farnesyltransferase inhibitor tipifarnib in children with refractory solid tumors or neurofibromatosis type I and plexiform neurofibromas","volume":"24","author":"Widemann","year":"2006","journal-title":"J. Clin. Oncol."},{"key":"B160","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1093\/neuonc\/nou004","article-title":"Phase 2 randomized, flexible crossover, double-blinded, placebo-controlled trial of the farnesyltransferase inhibitor tipifarnib in children and young adults with neurofibromatosis type 1 and progressive plexiform neurofibromas","volume":"16","author":"Widemann","year":"2014","journal-title":"Neuro Oncol."},{"key":"B161","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1111\/nph.14212","article-title":"The arabidopsis heat-intolerant 5 (hit5)\/enhanced response to aba 1 (era1) mutant reveals the crucial role of protein farnesylation in plant responses to heat stress","volume":"213","author":"Wu","year":"2017","journal-title":"New Phytol."},{"key":"B162","doi-asserted-by":"publisher","first-page":"e202303007","DOI":"10.1083\/jcb.202303007","article-title":"A farnesyl-dependent structural role for CENP-E in expansion of the fibrous corona","volume":"223","author":"Wu","year":"2024","journal-title":"J. Cell Biol."},{"key":"B163","doi-asserted-by":"publisher","first-page":"e1241","DOI":"10.1038\/cddis.2014.213","article-title":"Rasfonin, a novel 2-pyrone derivative, induces ras-mutated Panc-1 pancreatic tumor cell death in nude mice","volume":"5","author":"Xiao","year":"2014","journal-title":"Cell Death Dis."},{"key":"B164","doi-asserted-by":"publisher","first-page":"1267","DOI":"10.1105\/tpc.12.8.1267","article-title":"Functional requirement of plant farnesyltransferase during development in Arabidopsis","volume":"12","author":"Yalovsky","year":"","journal-title":"Plant Cell"},{"key":"B165","doi-asserted-by":"publisher","first-page":"1257","DOI":"10.1105\/tpc.12.8.1257","article-title":"Prenylation of the floral transcription factor APETALA1 modulates its function","volume":"12","author":"Yalovsky","year":"","journal-title":"Plant Cell"},{"key":"B166","first-page":"3569","article-title":"Farnesyltransferase inhibitors block the neurofibromatosis type I (NF1) malignant phenotype","volume":"55","author":"Yan","year":"1995","journal-title":"Cancer Res."},{"key":"B167","doi-asserted-by":"publisher","first-page":"10291","DOI":"10.1073\/pnas.0504641102","article-title":"Blocking protein farnesyltransferase improves nuclear blebbing in mouse","volume":"102","author":"Yang","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"B168","doi-asserted-by":"publisher","first-page":"3291","DOI":"10.1172\/JCI35876","article-title":"Progerin elicits disease phenotypes of progeria in mice whether or not it is farnesylated","volume":"118","author":"Yang","year":"2008","journal-title":"J. Clin. Invest."},{"key":"B169","doi-asserted-by":"publisher","first-page":"820","DOI":"10.1021\/ja209650h","article-title":"Insights into the mechanistic dichotomy of the protein farnesyltransferase peptide substrates CVIM and CVLS","volume":"134","author":"Yang","year":"2012","journal-title":"J. Am. Chem. Soc."},{"key":"B170","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1038\/s41556-024-01374-2","article-title":"Defective prelamin A processing promotes unconventional necroptosis driven by nuclear RIPK1","volume":"26","author":"Yang","year":"2024","journal-title":"Nat. Cell Biol."},{"key":"B171","doi-asserted-by":"publisher","first-page":"e13200","DOI":"10.1111\/acel.13200","article-title":"Targeting RAS-Converting enzyme 1 overcomes senescence and improves progeria-like phenotypes of ZMPSTE24 deficiency","volume":"19","author":"Yao","year":"2020","journal-title":"Aging Cell"},{"key":"B172","doi-asserted-by":"publisher","first-page":"5302","DOI":"10.1073\/pnas.88.12.5302","article-title":"A protein geranylgeranyltransferase from bovine brain: implications for protein prenylation specificity","volume":"88","author":"Yokoyama","year":"1991","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"B173","doi-asserted-by":"publisher","first-page":"e70374","DOI":"10.1111\/acel.70374","article-title":"Decreased PTGES2 farnesylation in granulosa cells compromises PGE2-Dependent cumulus expansion and oocyte maturation during ovarian aging","volume":"25","author":"Zhang","year":"2026","journal-title":"Aging Cell"},{"key":"B174","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1016\/j.ajog.2025.08.031","article-title":"Farnesylation-dependent kinetochore targeting of centromere protein F is essential for oocyte meiotic progression and female fertility","volume":"234","author":"Zhong","year":"2026","journal-title":"Am. J. Obstet. Gynecol."},{"key":"B175","doi-asserted-by":"publisher","first-page":"8557","DOI":"10.1073\/pnas.90.18.8557","article-title":"Isoprenylation of the plant molecular chaperone ANJ1 facilitates membrane association and function at high temperature","volume":"90","author":"Zhu","year":"1993","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"B176","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1038\/s41419-019-1688-9","article-title":"The alteration of RhoA geranylgeranylation and ras farnesylation breaks the integrity of the blood-testis barrier and results in hypospermatogenesis","volume":"10","author":"Zhu","year":"2019","journal-title":"Cell Death Dis."},{"key":"B177","doi-asserted-by":"publisher","first-page":"7633","DOI":"10.1073\/pnas.130189397","article-title":"Cloning of the arabidopsis WIGGUM gene identifies a role for farnesylation in meristem development","volume":"97","author":"Ziegelhoffer","year":"2000","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"B178","doi-asserted-by":"publisher","first-page":"4816","DOI":"10.1200\/JCO.2004.03.200","article-title":"Dose-ranging pharmacodynamic study of tipifarnib (R115777) in patients with relapsed and refractory hematologic malignancies","volume":"22","author":"Zimmerman","year":"2004","journal-title":"J. Clin. Oncol."}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2026.1907367\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T22:51:46Z","timestamp":1786747906000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2026.1907367\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,14]]},"references-count":178,"alternative-id":["10.3389\/fphar.2026.1907367"],"URL":"https:\/\/doi.org\/10.3389\/fphar.2026.1907367","relation":{},"ISSN":["1663-9812"],"issn-type":[{"value":"1663-9812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,14]]},"article-number":"1907367"}}